Advertisement Cubist selects Trial Interactive Platform as eTMF solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cubist selects Trial Interactive Platform as eTMF solution

TransPerfect, a US-based provider of e-clinical solutions and language services to the life sciences industry, has announced that Cubist has selected its Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs.

Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that combines clinical documentation and trial development.

TransPerfect’s Life Sciences Solutions division is committed to the e-clinical space and eTMF is just one of many Trial Interactive modules designed to support global clinical development.

Apart from eTMF, Trial Interactive provides solutions for site feasibility, study start-up, endpoint adjudication, pharmacovigilance, safety reporting, and more to provide a paperless clinical development platform.

It also offers real-time accessibility to study stakeholders on a global basis, advancing offerings in clinical development by facilitating efficient management of the TMF.

Clients will be able to meet both regulatory requirements and security needs worldwide, with the help of Trial Interactive’s globally accessible platform.

TransPerfect general manager Life Sciences Solutions Michael Smyth said trial Interactive will significantly improve efficiencies in managing final documentation through storing all final Trial Master File (TMF) documents electronically in a secure and regulatory-compliant manner.

"We’re proud to support Cubist in executing clinical development more efficiently, with a streamlined, paperless, and global eTMF solution," Smyth said.